Evaluation of a non-chemotherapy agent for the treatment of measurable tumors in dogs

Dr. Craig Clifford, DVM, MS, DACVIM (Oncology)
Primary Investigator

Dr. Kristin Kicenuik, DVM, DACVIM (Oncology), Dr. Christine Mullin, VMD, DACVIM (Oncology), Dr. Kate Vickery, VMD, MS, DACVIM (Oncology), CVA


Hope VS is excited to be participating in a clinical trial to evaluate a non-chemotherapy agent that utilizes an investigational mechanism of action for the treatment of palpable malignant tumors in dogs.

Qualifying malignant tumors include soft tissue sarcoma, mammary gland carcinoma, melanoma, lymphoma, mast cell tumor etc.

Study Funding:
This study is at no cost for the duration of the study (~ 1 month), including treatments and all study-related procedures. Owners can receive up to $150 in gas cards for participation.

Post completion of the study, there is some additional funding for additional therapies ($1,000) at Hope VS.

Eligibility Criteria:
•Have at least one measurable malignant tumor
•Weigh 5–50kgs
•Have normal or minimally diminished activity level
•No pulmonary or intra-abdominal metastasis
•Use of certain concomitant medications may be excluded

For more information, please contact us:

P: (610) 296-2099

E: [email protected]